CD8A and neoplasm: Nonetheless, even if allorecognition is playing a role in the rejection process, tumors in mice receiving splenocytes from Mam-A vaccinated mice eventually grew back indicating that although CD8 T cells specific for Mam-A2 initially induce tumor regression in vivo, this vaccination regime alone isn't sufficient to prevent tumor re-growth.